Udo Vetter - Gerresheimer AG Insider

Gerresheimer AG -- USA Stock  

USD 88.75  0.00  0.00%

Member of the Supervisory Board

Mr. Udo J. Vetter was Member of the Supervisory Board of Gerresheimer AG since May 14, 2007. He is a Pharmacist und General Partner of UVCap GmbH Co. KG, Ravensburg. He is also Chairman of the Supervisory Board at EDT AG, ItM AG, Vetter Pharma Fertigungs GmbH Co. KG, Paschal Werk G. Maier GmbH, Medisynthana GmbH, Atoll GmbH and SeaLionPharman Pte. Ltd. Furthermore, he is Member of the Supervisory Board at HSM GmbH Co. KG, K M Praezisionstechnik GmbH and Gland Pharma Pte. Ltd., among others. He was Managing Director of Vetter Injekt System GmbH Co. KG between 1989 and 2003. He was also Member of the Executive Committee of the Vetter Group between 1999 and 2003. In 2004 he was appointed as Managing Partner of the UVCap GmbH Co. KG private equity company. Since 2006 he has also been Managing Partner of the real estate holding MMC GmbH Co. KG. In 2007 he joined the Advisory Board of Vetter Pharma Fertigung GmbH Co. KG and since 2008 he was Advisory Board Chairman. In 2007 he was appointed to the Vetter Executive Committee. He graduated from University of Washington with BS in Pharmacy. He is Member of the Nomination Committee at the Company.
Age: 62  Executive Since 2007      
49 211 61 81 00  http://www.gerresheimer.com

Management Efficiency

The company has return on total asset (ROA) of 4.41 % which means that it generated profit of $4.41 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 12.56 % meaning that it generated $12.56 on every $100 dollars invested by stockholders.
The company has accumulated 1.13 B in total debt with debt to equity ratio (D/E) of 120.9 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Gerresheimer AG has Current Ratio of 0.71 indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due.

Similar Executives

Entity Summary

Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. Gerresheimer AG was founded in 1864 and is headquartered in Dsseldorf, Germany. Gerresheimer AG is traded on OTC Market in USA.Gerresheimer AG (GRRMF) is traded on OTC Market in USA. It is located in Klaus-Bungert-Strasse 4 and employs 9,808 people.

Did you try this?

Run Efficient Frontier Now

Efficient Frontier

Plot and analyze your portfolio and positions against risk-return landscape of the market.
Hide  View All  NextLaunch Efficient Frontier
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Gerresheimer AG to your portfolio

Top Management

Gerresheimer AG Leadership Team
Lukas Burkhardt, Executive, Ph.D
Andrea Abt, Executive
Severine Camp, Director
Markus Rocholz, Executive
Christian Fischer, CEO
Peter Noe, Executive, Ph.D
Lydia Armer, Executive
Karin Dorrepaal, Executive, Ph.D
Uwe Roehrhoff, Executive
Katja Moegel, Executive
Francesco Grioli, Chairman
Axel Herberg, Executive
Anke Linnarzt, Director
Theodor Stuth, Executive
Rainer Beaujean, CFO
Udo Vetter, Executive
Sonja Apel, Director
Gerhard Schulze, Chairman
Andreas Schuette, Executive
Eugen Heinz, Executive
Seppel Kraus, Executive

Stock Performance

Gerresheimer AG Performance Indicators